Bridges Investment Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.21M Buy
56,105
+254
+0.5% +$29.7K 0.09% 99
2026
Q1
$6.72M Sell
55,851
-884
-2% -$102K 0.09% 101
2025
Q4
$5.97M Sell
56,735
-2,267
-4% -$213K 0.08% 101
2025
Q3
$4.95M Buy
59,002
+2,734
+5% +$225K 0.06% 106
2025
Q2
$4.45M Sell
56,268
-178
-0.3% -$14.1K 0.06% 110
2025
Q1
$5.07M Sell
56,446
-2,743
-5% -$256K 0.07% 103
2024
Q4
$5.89M Sell
59,189
-1,125
-2% -$116K 0.08% 102
2024
Q3
$6.85M Sell
60,314
-5,857
-9% -$696K 0.1% 99
2024
Q2
$8.19M Buy
66,171
+21,816
+49% +$2.81M 0.12% 90
2024
Q1
$5.85M Sell
44,355
-2,408
-5% -$297K 0.18% 71
2023
Q4
$5.1M Buy
46,763
+1,698
+4% +$176K 0.17% 73
2023
Q3
$4.64M Sell
45,065
-15
-0% -$1.62K 0.16% 75
2023
Q2
$5.2M Sell
45,080
-10,457
-19% -$1.19M 0.17% 72
2023
Q1
$5.91M Sell
55,537
-750
-1% -$81K 0.21% 69
2022
Q4
$6.25M Buy
56,287
+1,500
+3% +$153K 0.23% 67
2022
Q3
$4.72M Sell
54,787
-800
-1% -$71.4K 0.18% 74
2022
Q2
$5.07M Sell
55,587
-1,750
-3% -$155K 0.18% 76
2022
Q1
$4.71M Sell
57,337
-2,658
-4% -$210K 0.15% 82
2021
Q4
$4.6M Sell
59,995
-3,755
-6% -$299K 0.13% 88
2021
Q3
$4.79M Sell
63,750
-1,425
-2% -$108K 0.15% 85
2021
Q2
$5.07M Sell
65,175
-5,122
-7% -$381K 0.15% 84
2021
Q1
$5.17M Sell
70,297
-757
-1% -$55.8K 0.15% 82
2020
Q4
$5.55M Sell
71,054
-2,756
-4% -$211K 0.17% 80
2020
Q3
$5.84M Sell
73,810
-1,074
-1% -$84.1K 0.2% 74
2020
Q2
$5.53M Sell
74,884
-3,131
-4% -$236K 0.2% 77
2020
Q1
$5.73M Sell
78,015
-2,477
-3% -$195K 0.26% 72
2019
Q4
$6.99M Sell
80,492
-7,663
-9% -$629K 0.26% 77
2019
Q3
$7.08M Sell
88,155
-777
-0.9% -$62.3K 0.27% 75
2019
Q2
$7.12M Sell
88,932
-1,941
-2% -$149K 0.27% 77
2019
Q1
$7.21M Sell
90,873
-2,381
-3% -$178K 0.29% 76
2018
Q4
$6.8M Buy
93,254
+3,117
+3% +$220K 0.32% 71
2018
Q3
$6.1M Buy
90,137
+2,340
+3% +$149K 0.3% 78
2018
Q2
$5.08M Sell
87,797
-673
-0.8% -$38K 0.23% 85
2018
Q1
$4.6M Buy
88,470
+11,852
+15% +$640K 0.21% 91
2017
Q4
$4.11M Sell
76,618
-778
-1% -$43.1K 0.33% 67
2017
Q3
$4.73M Buy
77,396
+28,731
+59% +$1.74M 0.45% 54
2017
Q2
$2.98M Buy
48,665
+7,409
+18% +$451K 0.4% 56
2017
Q1
$2.5M Sell
41,256
-23,627
-36% -$1.43M 0.35% 62
2016
Q4
$3.65M Buy
64,883
+3,446
+6% +$202K 0.52% 50
2016
Q3
$3.66M Sell
61,437
-147
-0.2% -$8.6K 0.61% 47
2016
Q2
$3.38M Buy
61,584
+22,052
+56% +$1.17M 0.59% 48
2016
Q1
$2M Buy
39,532
+9,965
+34% +$488K 0.36% 62
2015
Q4
$1.49M Buy
29,567
+1,395
+5% +$70.3K 0.27% 68
2015
Q3
$1.53M Hold
28,172
0.27% 68
2015
Q2
$1.53M Buy
28,172
+934
+3% +$52.4K 0.27% 68
2015
Q1
$1.49M Sell
27,238
-262
-1% -$14.8K 0.26% 66
2014
Q4
$1.49M Buy
27,500
+3,925
+17% +$219K 0.26% 69
2014
Q3
$1.33M Buy
23,575
+2,149
+10% +$121K 0.25% 71
2014
Q2
$1.18M Hold
21,426
0.23% 75
2014
Q1
$1.16M Buy
21,426
+2,681
+14% +$139K 0.24% 73
2013
Q4
$894K Buy
18,745
+629
+3% +$28.8K 0.2% 79
2013
Q3
$823K Buy
18,116
+30
+0.2% +$1.37K 0.2% 79
2013
Q2
$802K Buy
+18,086
New +$808K 0.21% 76

Other funds holding MRK

Bridges Investment Management's MRK Position: Q2 2026 in Review

Bridges Investment Management increased its Merck (MRK) stake by 0.45% in Q2 2026, buying an estimated $29.7K and bringing the position to 56,105 shares worth $7.21M. The position accounts for 0.09% of the portfolio, ranked #99.

Bridges Investment Management first reported a position in MRK in Q2 2013 and has held it in 53 quarters since. The position peaked at $8.19M in Q2 2024. 2,532 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Bridges Investment Management held 56,105 shares of Merck worth $7.21M as of Q2 2026.
  • Bridges Investment Management bought 254 Merck shares in Q2 2026, an estimated $29.7K.
  • Merck made up 0.09% of Bridges Investment Management's portfolio in Q2 2026, its #99 holding.
  • Bridges Investment Management first reported a position in Merck in Q2 2013 and has held it in 53 quarters since.
  • Bridges Investment Management's Merck position peaked at $8.19M in Q2 2024.
  • 2,532 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Bridges Investment Management's 13F filing for Q2 2026, filed 7 Aug 2026.